Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ann & Robert H Lurie Children's Hospital of Chicago
With
University of Minnesota
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
A large number of children with cGVHD have to deal with many years of a disfiguring and painful chronic illness with the side effects of long term steroid use. The number of stem cell transplants done in children is only growing given that we are now transplanting patients with a variety of nonmalignant disorders and given the use of alternative donor sources. The broad categories of limited and extensive cGVHD are recognized by clinicians, but are not particularly useful in clinical practice. Since cGVHD may involve almost every organ system adn since cGVHD constitutes a waxing and waning nature, cGVHD makes clinical management very difficult and complicated. Currently, there is a symptoms scale used in the adult population for measuring symptom burden for adults with cGVHD. This scale is called the "Lee Symptoms Scale". The purpose of this project is to develop a scale that is similar in design to the Lee Scale, but it is specifically designed to measure the burden of cGVHD in the pediatric population
Age
5–18
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
5-18 years of age
Prior allogeneic Stem Cell Transplant, with any graft source, donor type, and GVHD prophylaxis allowed
Clinical diagnosis of cGVHD
Need for systemic treatment, defined as any medication or intervention delivered
No evidence of primary disease relapse
Signed, informed consent, and if applicable, adolescent assent